Non-peptide opioid receptor ligands - recent advances. Part II - antagonists

Curr Med Chem. 2002 Sep;9(17):1591-603. doi: 10.2174/0929867023369358.

Abstract

This paper is the second part of the review on opioid receptor ligands and deals with the progress in the field of non-peptide opioid receptor antagonists (starting from the pioneering opiate studies in the early seventies) with particular stress on the last decade accomplishments. As X-ray high resolution structure determination of the ligand-receptor systems for G protein-coupled receptors meets with considerable experimental obstacles, the knowledge about ligand interactions with the membrane-bound receptors traditionally derives from structure-activity studies. Hence, such a concise summary, collecting chemically distinct but pharmalogically relative compounds, may be a convenient information source for any research concerning ligand-opioid receptor binding or rational drug design.

Publication types

  • Review

MeSH terms

  • Animals
  • Binding Sites
  • Humans
  • Isoquinolines / chemistry
  • Isoquinolines / pharmacology
  • Ligands
  • Morphine / chemistry
  • Morphine / pharmacology
  • Narcotic Antagonists*
  • Piperazines / chemistry
  • Piperazines / pharmacology
  • Piperidines / chemistry
  • Piperidines / pharmacology
  • Quinolines / chemistry
  • Quinolines / pharmacology
  • Receptors, Opioid / chemistry
  • Receptors, Opioid / classification
  • Structure-Activity Relationship

Substances

  • Isoquinolines
  • Ligands
  • Narcotic Antagonists
  • Piperazines
  • Piperidines
  • Quinolines
  • Receptors, Opioid
  • Morphine